Literature DB >> 18987674

A cell penetrating heme oxygenase protein protects heart graft against ischemia/reperfusion injury.

J Ma1, C K Lau, A Obed, A Dada, A Doenecke, S T Fan, H J Schlitt, T Y Tsui.   

Abstract

Ischemia/reperfusion (I/R) injury is an unavoidable barrier that significantly affects outcome of solid organ transplantation. Here, we establish a protein transduction system to extend graft preservation time and to prevent I/R injury in heart transplantation. We generated a recombinant heme oxygenase-1 (HO-1) protein containing a modified protein transduction domain (PTD). PTD could cross cover cell membrane and carry target molecule to parenchymal cells of cold-preserved heart grafts. The newly generated PTD-HO-1 protein localized mainly in subcellular membrane organelle and nucleus after delivery that significantly prolonged cold preservation of heart grafts. This effect was associated with significantly less endothelial cell activation, less neutrophil and macrophage infiltration in PTD-HO-1-transduced heart grafts after reperfusion as compared with controls. In addition, transduction of PTD-HO-1 protein to heart graft significantly suppressed the I/R injury-associated myocardiocyte apoptosis. The infarct areas of heart graft after I/R injury were significantly reduced after PTD-HO-1 protein treatment. We show here for the first time that PTD can maintain its biological activities during cold preservation. Transduction of cell penetrating HO-1 protein significantly prolongs the cold preservation time and protects the graft from the I/R injury. This approach represents a novel method for the improvement of the overall outcome of organ transplantation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18987674     DOI: 10.1038/gt.2008.162

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  7 in total

1.  Organ Preservation: Current Concepts and New Strategies for the Next Decade.

Authors:  Edgardo E Guibert; Alexander Y Petrenko; Cecilia L Balaban; Alexander Y Somov; Joaquín V Rodriguez; Barry J Fuller
Journal:  Transfus Med Hemother       Date:  2011-03-21       Impact factor: 3.747

2.  Heme oxygenase-1 inhibits myoblast differentiation by targeting myomirs.

Authors:  Magdalena Kozakowska; Maciej Ciesla; Anna Stefanska; Klaudia Skrzypek; Halina Was; Agnieszka Jazwa; Anna Grochot-Przeczek; Jerzy Kotlinowski; Agnieszka Szymula; Aleksandra Bartelik; Milena Mazan; Oleksandr Yagensky; Urszula Florczyk; Krzysztof Lemke; Anna Zebzda; Grzegorz Dyduch; Witold Nowak; Krzysztof Szade; Jacek Stepniewski; Marcin Majka; Rafal Derlacz; Agnieszka Loboda; Jozef Dulak; Alicja Jozkowicz
Journal:  Antioxid Redox Signal       Date:  2011-10-19       Impact factor: 8.401

Review 3.  Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity.

Authors:  Joseph Fomusi Ndisang
Journal:  Mediators Inflamm       Date:  2010-05-18       Impact factor: 4.711

Review 4.  Heme Oxygenase-1 and Carbon Monoxide in the Heart: The Balancing Act Between Danger Signaling and Pro-Survival.

Authors:  Leo E Otterbein; Roberta Foresti; Roberto Motterlini
Journal:  Circ Res       Date:  2016-06-10       Impact factor: 17.367

5.  Cell-penetrating heme oxygenase-1 in the therapy of atopic dermatitis in mice.

Authors:  Fang Tang; Xueqing Ma; Jiayu Sun; Minghui Ru; Tiansheng Qian; Wengjing Ji; Sifan Qian; Hua Li
Journal:  Exp Ther Med       Date:  2021-07-01       Impact factor: 2.447

6.  Gene transfer of heme oxygenase-1 using an adeno-associated virus serotype 6 vector prolongs cardiac allograft survival.

Authors:  Jacqueline M Evans; Sonia Navarro; Tomoko Doki; John M Stewart; Noboru Mitsuhashi; Mary Kearns-Jonker
Journal:  J Transplant       Date:  2012-10-16

7.  The protective effect of Bcl-xl overexpression against oxidative stress-induced vascular endothelial cell injury and the role of the Akt/eNOS pathway.

Authors:  Leng Ni; Tianjia Li; Bao Liu; Xitao Song; Genhuan Yang; Linfang Wang; Shiying Miao; Changwei Liu
Journal:  Int J Mol Sci       Date:  2013-11-08       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.